EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles

Lance T Dockery, Marie-Christine Daniel iD

Pharmaceutics · 09.08.2023 · 15 (8) · 2103

DOI: 10.3390/pharmaceutics15082103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.08.2023. Verfasst von Lance T Dockery und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Maryland Baltimore County (UMBC), Baltimore, MD 21250, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NSF, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system.

Schlagwörter

Stichwörter der Autor:innen

dendronsdoxorubicingold nanoparticlesprostate cancertargeted delivery

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Maryland Baltimore County (UMBC), Baltimore, MD 21250, USA.

ORCID-Profile: Marie-Christine Daniel

Förderung

  • NIH HHS
  • NSF
  • NIH
  • University of Maryland, Baltimore County

Zitieren

APA

Dockery, L. T., & Daniel, M. C. (2023). Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles. Pharmaceutics, 15(8), 2103. https://doi.org/10.3390/pharmaceutics15082103

Vancouver

Dockery LT, Daniel MC. Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles. Pharmaceutics. 2023;15(8):2103. doi:10.3390/pharmaceutics15082103

BibTeX
@article{Dockery2023,
  author = {Dockery, Lance T and Daniel, Marie-Christine},
  title = {Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {2103},
  doi = {10.3390/pharmaceutics15082103}
}
Kostenlos starten →